ImmunityBio (IBRX) Earnings Date, Estimates & Call Transcripts $6.36 +0.08 (+1.27%) (As of 07/5/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 9) -$0.20 Missed By -$0.04 Consensus EPS (May. 9) -$0.16 Get ImmunityBio Earnings AlertsEnter your email address below to receive the latest news and earnings results for IBRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIBRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IBRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin Analytics50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks – including NVDA – stumbling?To see this July stock warning for yourself – 100% free – click here. ImmunityBio Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.75) EPSNext Year EPS Consensus Estimate: ($0.52) EPSIBRX Earnings Date and InformationImmunityBio last posted its earnings data on May 9th, 2024. The reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.04. The company had revenue of $0.04 million for the quarter, compared to analysts' expectations of $0.03 million. ImmunityBio has generated ($1.09) earnings per share over the last year (($1.09) diluted earnings per share). Earnings for ImmunityBio are expected to grow in the coming year, from ($0.75) to ($0.52) per share. ImmunityBio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More ImmunityBio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/9/2024Q1 2024($0.16)($0.20)($0.04)($0.20)$0.03 million$0.04 million3/19/2024Q4 2023($0.18)($0.19)($0.01)-$0.03 million$0.14 million11/8/2023Q3 2023($0.27)($0.19)+$0.08($0.19)-$0.08 million8/8/2023Q2 2023($0.26)($0.28)($0.02)($0.24)$0.03 million$0.04 million5/11/2023Q1 2023($0.27)($0.27)-($0.27)-$0.36 million11/8/2022Q3 2022($0.23)($0.28)($0.05)($0.28)$0.03 million$0.12 million Get the Latest News and Ratings for IBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunityBio and its competitors with MarketBeat's FREE daily newsletter. 5/10/2022Q1 2022($0.22)($0.26)($0.04)($0.26)$0.03 million$0.01 million8/12/2021Q2 2021($0.12)($0.23)($0.11)($0.23)$0.03 million$0.34 million8/7/2020Q2 2020($0.19)($0.20)($0.01)($0.20)--5/11/2020Q1 2020($0.17)($0.19)($0.02)($0.19)-$0.02 million3/25/2020Q4 2019($0.20)($0.16)+$0.04($0.16)-$0.01 million11/5/2019Q3 2019-($0.16)($0.16)($0.16)-$0.01 million8/6/2019Q2 2019($0.25)($0.17)+$0.08($0.17)-$0.02 million ImmunityBio Earnings - Frequently Asked Questions When is ImmunityBio's earnings date? ImmunityBio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on IBRX's earnings history. Did ImmunityBio beat their earnings estimates last quarter? In the previous quarter, ImmunityBio (NASDAQ:IBRX) missed the analysts' consensus estimate of ($0.16) by $0.04 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. IBRX's actual earnings. How much revenue does ImmunityBio generate each year? ImmunityBio (NASDAQ:IBRX) has a recorded annual revenue of $620,000.00. How much profit does ImmunityBio generate each year? ImmunityBio (NASDAQ:IBRX) has a recorded net income of -$583.20 million. IBRX has generated -$1.09 earnings per share over the last four quarters. What is ImmunityBio's EPS forecast for next year? ImmunityBio's earnings are expected to grow from ($0.75) per share to ($0.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: TG Therapeutics Earnings Date Harmony Biosciences Earnings Date Veracyte Earnings Date Sage Therapeutics Earnings Date Fulgent Genetics Earnings Date iTeos Therapeutics Earnings Date Alector Earnings Date Taysha Gene Therapies Earnings Date Precigen Earnings Date Aura Biosciences Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Analysts and Earnings Propel the S&P 500's Continuous GrowthBlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings Drop This page (NASDAQ:IBRX) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunityBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunityBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.